Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3418 | (-)-Lariciresinol |
| 1. Lariciresinol administration can inhibit the tumor growth and tumor angiogenesis, conceivable importance of dietary lignan lariciresinol in inhibition of breast cancer development. | |
| BCN3433 | Zingibroside R1 |
| 1. Zingibroside R1 has anti-HIV-1 activity. | |
| BCN3438 | Paederosidic acid |
| Paederosidic acid has significant anti-tumor, anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain, and it up-regulates expressions of GAD 65, may be a promising future therapeutic agent for treatment of epilepsy. | |
| BCN3478 | 1-Hydroxy-2-methylanthraquinone |
| 1. 1-Hydroxy-2-methylanthraquinone exhibits promising larvicidal activity. | |
| BCN3479 | Alizarin |
| Alizarin has a selective and effective inhibitory activity towards cancerous cells, it acts through the inhibition of ERK phosphorylation and cell cycle arrest in the S-phase. Alizarin has antigenotoxic activity, which can be explained by inhibition of CYP activities responsible for activating the mutagens. | |
